Ligat L - Search Results

1

Tripartite split-GFP assay to identify selective intracellular nanobody that suppresses GTPase RHOA subfamily downstream signaling.

Keller L, Tardy C, Ligat L, Le Pennec S, Bery N, Koraïchi F, Chinestra P, David M, Gence R, Favre G, Cabantous S, Olichon A. Keller L, et al. Among authors: ligat l. Front Immunol. 2022 Aug 18;13:980539. doi: 10.3389/fimmu.2022.980539. eCollection 2022. Front Immunol. 2022. PMID: 36059552 Free PMC article.

2

Generation of a single chain antibody variable fragment (scFv) to sense selectively RhoB activation.

Chinestra P, Olichon A, Medale-Giamarchi C, Lajoie-Mazenc I, Gence R, Inard C, Ligat L, Faye JC, Favre G. Chinestra P, et al. Among authors: ligat l. PLoS One. 2014 Nov 3;9(11):e111034. doi: 10.1371/journal.pone.0111034. eCollection 2014. PLoS One. 2014. PMID: 25365345 Free PMC article.

3

NaLi-H1: A universal synthetic library of humanized nanobodies providing highly functional antibodies and intrabodies.

Moutel S, Bery N, Bernard V, Keller L, Lemesre E, de Marco A, Ligat L, Rain JC, Favre G, Olichon A, Perez F. Moutel S, et al. Among authors: ligat l. Elife. 2016 Jul 19;5:e16228. doi: 10.7554/eLife.16228. Elife. 2016. PMID: 27434673 Free PMC article.

4

Selection and Characterization of a Nanobody Biosensor of GTP-Bound RHO Activities.

Keller L, Bery N, Tardy C, Ligat L, Favre G, Rabbitts TH, Olichon A. Keller L, et al. Among authors: ligat l. Antibodies (Basel). 2019 Jan 9;8(1):8. doi: 10.3390/antib8010008. Antibodies (Basel). 2019. PMID: 31544814 Free PMC article.

5

Nanobody-Based Quantification of GTP-Bound RHO Conformation Reveals RHOA and RHOC Activation Independent from Their Total Expression in Breast Cancer.

Keller L, Tardy C, Ligat L, Gilhodes J, Filleron T, Bery N, Rochaix P, Aquilina A, Bdioui S, Roux T, Trinquet E, Favre G, Olichon A. Keller L, et al. Among authors: ligat l. Anal Chem. 2021 Apr 20;93(15):6104-6111. doi: 10.1021/acs.analchem.0c05137. Epub 2021 Apr 7. Anal Chem. 2021. PMID: 33825439

6

Self-activation of Vγ9Vδ2 T cells by exogenous phosphoantigens involves TCR and butyrophilins.

Laplagne C, Ligat L, Foote J, Lopez F, Fournié JJ, Laurent C, Valitutti S, Poupot M. Laplagne C, et al. Among authors: ligat l. Cell Mol Immunol. 2021 Aug;18(8):1861-1870. doi: 10.1038/s41423-021-00720-w. Epub 2021 Jun 28. Cell Mol Immunol. 2021. PMID: 34183807 Free PMC article.

7

Structure-guided design of pyridoclax derivatives based on Noxa / Mcl-1 interaction mode.

Hedir S, De Giorgi M, Fogha J, De Pascale M, Weiswald LB, Brotin E, Marekha B, Denoyelle C, Denis C, Suzanne P, Gautier F, Juin P, Ligat L, Lopez F, Carlier L, Legay R, Bureau R, Rault S, Poulain L, Oliveira Santos JS, Voisin-Chiret AS. Hedir S, et al. Among authors: ligat l. Eur J Med Chem. 2018 Nov 5;159:357-380. doi: 10.1016/j.ejmech.2018.10.003. Epub 2018 Oct 4. Eur J Med Chem. 2018. PMID: 30308410

8

Single-cell spatial explorer: easy exploration of spatial and multimodal transcriptomics.

Pont F, Cerapio JP, Gravelle P, Ligat L, Valle C, Sarot E, Perrier M, Lopez F, Laurent C, Fournié JJ, Tosolini M. Pont F, et al. Among authors: ligat l. BMC Bioinformatics. 2023 Jan 27;24(1):30. doi: 10.1186/s12859-023-05150-1. BMC Bioinformatics. 2023. PMID: 36707753 Free PMC article.

9

Interaction between hormone-sensitive lipase and ChREBP in fat cells controls insulin sensitivity.

Morigny P, Houssier M, Mairal A, Ghilain C, Mouisel E, Benhamed F, Masri B, Recazens E, Denechaud PD, Tavernier G, Caspar-Bauguil S, Virtue S, Sramkova V, Monbrun L, Mazars A, Zanoun M, Guilmeau S, Barquissau V, Beuzelin D, Bonnel S, Marques M, Monge-Roffarello B, Lefort C, Fielding B, Sulpice T, Astrup A, Payrastre B, Bertrand-Michel J, Meugnier E, Ligat L, Lopez F, Guillou H, Ling C, Holm C, Rabasa-Lhoret R, Saris WHM, Stich V, Arner P, Rydén M, Moro C, Viguerie N, Harms M, Hallén S, Vidal-Puig A, Vidal H, Postic C, Langin D. Morigny P, et al. Among authors: ligat l. Nat Metab. 2019 Jan;1(1):133-146. doi: 10.1038/s42255-018-0007-6. Epub 2018 Dec 3. Nat Metab. 2019. PMID: 32694809

10

Nurse-like cells promote CLL survival through LFA-3/CD2 interactions.

Boissard F, Tosolini M, Ligat L, Quillet-Mary A, Lopez F, Fournié JJ, Ysebaert L, Poupot M. Boissard F, et al. Among authors: ligat l. Oncotarget. 2016 Nov 26;8(32):52225-52236. doi: 10.18632/oncotarget.13660. eCollection 2017 Aug 8. Oncotarget. 2016. PMID: 28881725 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

27 results

Search Page